UK-based CRO launches new kinase compound profiling services

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/marchmeena29)
(Image: Getty/marchmeena29)

Related tags: Aurelia Bioscience, CRO, Compound profiling

Aurelia Bioscience is now offering kinase compound profiling services using Promega’s NanoBRET technology.

Aurelia Bioscience is a contract research organization (CRO) specializing in customized bioassay development, pharmacological profiling, and compound screening.

Aurelia Bioscience Chief Scientific Officer Gary Allenby said the BioCity​, Nottingham-based firm is the only CRO in the UK to use Promega’s NanoBRET technology for kinase compound profiling.

Headquartered in Madison, WI, US, Promega’s NanoBRET technology enables reproducible detection of protein interactions in the natural cellular environment, according to the company, which provides products across the fields of genomics, protein analysis and expression, cellular analysis, drug discovery, and genetic identity.

Although recently launched, Allenby said the company has already started receiving several inquiries for the new service, "which proves that there is a high demand.”

“Using Promega’s NanoBRET technology, Aurelia Bioscience has implemented intracellular kinase assays designed to study the interaction of compounds on kinase targets in intact living cells,” ​Allenby added.

“This technique is compatible with analysis under equilibrium conditions, suitable for a wide range of throughput requirements and a good predictor of cellular potency.”

Allenby said the company hopes to contribute to several kinase drug discovery programs in the next few months.

Related news

Show more

Related products

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more